| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
27,480,000 |
| Market
Cap: |
45.34(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.29 - $2.38 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Synthetics |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Dyadic International is a global biotechnology platform company and it utilizes a number of third-party consultants and research organizations to carry out its activities. Co. has developed a gene expression platform for producing commercial quantities of enzymes and other proteins. This technology is based on the Thermothelomyces heterothallica fungus, which Co. named C1. The C1-cell protein production platform is a versatile thermophilic filamentous fungal expression system for the development and production of biologic products including enzymes and other proteins.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
8,943 |
| Total Sell Value |
$0 |
$0 |
$0 |
$31,202 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pinnacle Fund L P |
10% Owner |
– – • |
2008-11-17 |
4 |
B |
$0.20 |
$4,589 |
I/I |
23,400 |
1,813,972 |
1.42 |
- |
|
| Pinnacle Fund L P |
10% Owner |
– – • |
2007-10-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,790,572 |
|
- |
|
| Emerson Steve |
10% Owner |
– – • |
2007-10-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,122,100 |
|
- |
|
| Juda Nancy |
10% Owner |
– – • |
2007-10-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
395,100 |
|
- |
|
| Dela Pointe Lisa M |
Interim Chief Financial Office |
• – – |
2007-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2006-11-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(214,800) |
0 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2006-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
107,400 |
167,400 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2006-09-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(60,000) |
214,800 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2006-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
|
- |
|
| Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2006-05-01 |
4 |
OE |
$3.33 |
$741,048 |
D/D |
222,537 |
4,769,578 |
|
- |
|
| Emalfarb Mark A |
Chief Executive Officer |
• • • |
2006-05-01 |
4 |
OE |
$3.33 |
$836,822 |
I/I |
251,298 |
5,822,125 |
|
- |
|
| Nedwin Glenn E |
Chief Scientific OfficerOffice |
• • – |
2006-03-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,990 |
|
- |
|
| Francisco Trust Under Agreement Dated February 28, |
officerTitle |
– – • |
2006-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
4,547,041 |
|
- |
|
| Warner Stephen J |
officerTitle |
– • – |
2005-12-02 |
4 |
S |
$2.11 |
$2,110 |
I/I |
(1,000) |
274,800 |
|
- |
|
| Warner Stephen J |
officerTitle |
– • – |
2005-11-30 |
4 |
S |
$2.08 |
$25,220 |
I/I |
(12,000) |
275,800 |
|
- |
|
| Warner Stephen J |
officerTitle |
– • – |
2005-11-29 |
4 |
S |
$2.06 |
$2,060 |
I/I |
(1,000) |
287,800 |
|
- |
|
| Warner Stephen J |
officerTitle |
– • – |
2005-11-23 |
4 |
S |
$2.24 |
$448 |
I/I |
(200) |
288,800 |
|
- |
|
| Warner Stephen J |
officerTitle |
– • – |
2005-11-21 |
4 |
S |
$2.26 |
$6,800 |
I/I |
(3,000) |
289,000 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2005-06-09 |
4 |
S |
$2.58 |
$20,700 |
I/I |
(8,000) |
292,000 |
|
- |
|
| Levin Robert S |
10% Owner |
– – • |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,056 |
|
- |
|
| Warner Stephen J |
Director |
– • – |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
300,000 |
|
- |
|
| Sproat Kent Michael |
Exec. VP - Enzyme Bus. Systems |
• – – |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
53,716 |
|
- |
|
| Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,422,041 |
|
- |
|
| Emalfarb Mark A |
President, CEO & ChairmanOffic |
• • • |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,570,827 |
|
- |
|
| Chandra Ratnesh |
Sr. VP-Marketing-Biotechnology |
• – – |
2005-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,716 |
|
- |
|
101 Records found
|
|
Page 4 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (0.6%) 
